N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples